Dr Rüya Eskimergen Nielsen from Novo Nordisk—the leading healthcare provider and developers of medical devices for treating diabetes, haemostasis management, growth hormone therapy, and hormone replacement therapy—provided insights into the benefits of rational materials selection using CES Selector (now GRANTA Selector) during her presentation as guest speaker at Granta’s ‘Materials Information Technology in Industry’ seminar in Denmark.